Cambridge, United Kingdom

Donna Freeman

This inventor holds 1 USPTO granted patent. Top assignee: Acambis Inc.. Active years: 2003.


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 19(Granted Patents)


Company Filing History:


Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Donna Freeman

Introduction

Donna Freeman is a notable inventor based in Cambridge, GB. He has made significant contributions to the field of immunization through his innovative research and inventions. His work focuses on developing methods to combat infections, particularly those caused by Helicobacter.

Latest Patents

Freeman holds a patent for the "Use of Salmonella vectors for vaccination against Helicobacter infection." This invention provides a method of immunization against Helicobacter, involving mucosal administration of an attenuated Salmonella vector that includes a nucleic acid molecule encoding a Helicobacter antigen. Additionally, it involves parenteral administration of a soluble Helicobacter antigen, co-administered with a suitable parenteral adjuvant. The invention also includes attenuated Salmonella vectors for use in this method. He has 1 patent to his name.

Career Highlights

Freeman has had a distinguished career, working with Acambis Inc., where he has been able to apply his innovative ideas in a practical setting. His research has contributed to advancements in vaccine development, showcasing his commitment to improving public health.

Collaborations

Throughout his career, Freeman has collaborated with esteemed colleagues, including Patricia Londono-Arcila and Thomas P Monath. These partnerships have further enhanced the impact of his work in the field of immunization.

Conclusion

Donna Freeman's contributions to the field of immunization through his innovative patent demonstrate his dedication to advancing medical science. His work continues to influence the development of effective vaccination methods against Helicobacter infections.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…